Bacterial cellulose in biomedical applications: A review.

Bacterial cellulose (BC) derived materials represents major advances to the current regenerative and diagnostic medicine. BC is a highly pure, biocompatible and versatile material that can be utilized in several applications - individually or in the combination with different components (e.g.

Bioactive nanocomposites of bacterial cellulose and natural hydrocolloids.

The aim of this work was to develop bioactive films from bacterial cellulose and hydrocolloids (guar gum and hyaluronic acid), coated or not with collagen. After mechanical treatment, a suspension of cellulose nanofibres was obtained which, combined with the dispersions of hydrocolloids, was used to produce bionanocomposite films by wet casting. The materials were stable in physiological solution and presented better swelling capacity than that of the bacterial cellulose.

Lysozyme-triggered epidermal growth factor release from bacterial cellulose membranes controlled by smart nanostructured films.

A novel wound-dressing biodevice, sensitive to lysozyme, an enzyme commonly found at infected skin wounds, was assembled by the layer-by-layer deposition of nanopolymeric chitosan and alginate films onto oxidized bacterial cellulose membranes incorporated with epidermal growth factor (EGF). Distinct EGF release profiles were obtained according to specific stimuli caused by infection. In in vitro conditions simulating noninfected wounds, the EGF rate and burst release effect were reduced by three deposited layers (Mt /M∞ of 0.